- Jan 18, 2001
- 3,462
- 1,153
- 113
- School/Org
- ODwire
- City
- Lansdale
- State
- PA
PHOENIX, July 30, 2025—Outcomes from a new study indicate that professional athletes using RevitalVision’s digital training program experienced significant improvements in visual acuity, contrast sensitivity, and steroacuity. These enhancements may provide a competitive advantage with stronger overall performance on the field.
The randomized control trial involved professional football (soccer) players aged 17 to 34 from Standard Liege, a top-tier Belgian club. Over the course of two months, participants completed 30 sessions of RevitalVision’s training program. On average, players in the treatment group improved their visual acuity by 1.1 lines on the ETDRS chart and saw an 87% increase in contrast sensitivity. They also demonstrated significant gains in depth perception, with stereoacuity thresholds improving from 125 to 22.25 seconds of arc.
Led by Dr. Sarah Maling—an ophthalmologist and researcher affiliated with the University of Oxford—the study was designed to explore how perceptual learning can enhance visual performance of elite athletes with normal 20/20 vision.
“These findings reinforce the potential for vision training to deliver measurable benefits beyond traditional clinical settings,” said Maling. “For professional athletes, these improvements can translate directly onto the field, enhancing tracking, situational awareness, and overall precision.”
While the study focused on visual function improvements, existing sports vision research sugguests that enhanced perceptual skills are closely tied to on-field performance.
“This research underscores the potential for perceptual training tools not only to aid clinical populations, but also to help athletes and others seeking to optimize their visual abilities for demanding activities,” said Yair Yahav, Founder and CEO, RevitalVision. “RevitalVision presents a unique, non-invasive approach for athletes to boost their visual capabilities and potentially improve their performance both on and off the field.”
RevitalVision’s personalized, software-based approach to perceptual learning is the only FDA-cleared product for amblyopia beyond childhood ages nine and older. The prescribed, home-based vision training software gives eye care professionals a unique tool to improve vision in diverse conditions including amblyopia, keratoconus, nystagmus, and early presbyopia by focusing on proprietary, personalized cortical visual stimulation.
To learn more about RevitalVision, visit www.revitalvision.com.
About RevitalVision
With offices in the U.S. and Israel, RevitalVision is committed to providing cutting-edge digital solutions that enhance visual clarity. Its innovative training software is the only FDA-cleared product for amblyopia in individuals aged 9+ and is clinically proven to improve vision across a variety of eye diseases and visual impairments including corneal and retinal diseases, post-cataract and laser refractive-surgery, sports vision training, and more. Providing real-time progress tracking and customizable routines, RevitalVision empowers individuals to take control of their vision health and experience lasting improvements in their well-being. For more information, visit www.revitalvision.com.
The randomized control trial involved professional football (soccer) players aged 17 to 34 from Standard Liege, a top-tier Belgian club. Over the course of two months, participants completed 30 sessions of RevitalVision’s training program. On average, players in the treatment group improved their visual acuity by 1.1 lines on the ETDRS chart and saw an 87% increase in contrast sensitivity. They also demonstrated significant gains in depth perception, with stereoacuity thresholds improving from 125 to 22.25 seconds of arc.
Led by Dr. Sarah Maling—an ophthalmologist and researcher affiliated with the University of Oxford—the study was designed to explore how perceptual learning can enhance visual performance of elite athletes with normal 20/20 vision.
“These findings reinforce the potential for vision training to deliver measurable benefits beyond traditional clinical settings,” said Maling. “For professional athletes, these improvements can translate directly onto the field, enhancing tracking, situational awareness, and overall precision.”
While the study focused on visual function improvements, existing sports vision research sugguests that enhanced perceptual skills are closely tied to on-field performance.
“This research underscores the potential for perceptual training tools not only to aid clinical populations, but also to help athletes and others seeking to optimize their visual abilities for demanding activities,” said Yair Yahav, Founder and CEO, RevitalVision. “RevitalVision presents a unique, non-invasive approach for athletes to boost their visual capabilities and potentially improve their performance both on and off the field.”
RevitalVision’s personalized, software-based approach to perceptual learning is the only FDA-cleared product for amblyopia beyond childhood ages nine and older. The prescribed, home-based vision training software gives eye care professionals a unique tool to improve vision in diverse conditions including amblyopia, keratoconus, nystagmus, and early presbyopia by focusing on proprietary, personalized cortical visual stimulation.
To learn more about RevitalVision, visit www.revitalvision.com.
# # #
About RevitalVision
With offices in the U.S. and Israel, RevitalVision is committed to providing cutting-edge digital solutions that enhance visual clarity. Its innovative training software is the only FDA-cleared product for amblyopia in individuals aged 9+ and is clinically proven to improve vision across a variety of eye diseases and visual impairments including corneal and retinal diseases, post-cataract and laser refractive-surgery, sports vision training, and more. Providing real-time progress tracking and customizable routines, RevitalVision empowers individuals to take control of their vision health and experience lasting improvements in their well-being. For more information, visit www.revitalvision.com.
